Drug Shortage Report for FOLIC ACID INJECTION, USP

Last updated on 2021-06-17 History
Report ID 136531
Drug Identification Number 02139480
Brand name FOLIC ACID INJECTION, USP
Common or Proper name Folic Acid Injection 5 mg/mL MD Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) FOLIC ACID
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 mL
ATC code B03BB
ATC description VITAMIN B12 AND FOLIC ACID
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-01
Estimated end date 2021-06-14
Actual end date 2021-06-16
Shortage status Resolved
Updated date 2021-06-17
Company comments Folic Acid Injection 5 mg/mL MD Vial 10 mL will be placed on 50% allocation effective April 1, 2021 to May 31, 2021 with an anticipated backorder effective June 1, 2021 to June 14, 2021.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-06-17 English Compare
v11 2021-06-15 French Compare
v10 2021-06-15 English Compare
v9 2021-04-05 French Compare
v8 2021-04-05 English Compare
v7 2021-04-05 French Compare
v6 2021-04-05 English Compare
v5 2021-04-05 French Compare
v4 2021-04-05 English Compare
v3 2021-04-02 English Compare
v2 2021-03-29 French Compare
v1 2021-03-29 English Compare

Showing 1 to 12 of 12